August 31, 2014 4:15 AM ET

Pharmaceuticals

Company Overview of Cerimon Pharmaceuticals, Inc.

Company Overview

Cerimon Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics for autoimmune diseases, inflammation, and pains in the United States and Europe. It develops Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, including pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. Cerimon Pharmaceuticals, Inc. was founded in 2004 and is headquartered in South San Francisco, California.

701 Gateway Boulevard

Suite 100

South San Francisco, CA 94080

United States

Founded in 2004

Phone:

650-827-4000

Fax:

650-827-4040

Key Executives for Cerimon Pharmaceuticals, Inc.

Founder and Executive Director
Age: 55
Co-Founder and Director
Age: 56
Co-Founder
Age: 51
Vice President of Business Development & Licensing and General Counsel
Age: 44
Senior Vice President of Pharmaceutical Product Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Cannex Therapeutics LLC United States
AMS Health Sciences, Inc. United States
RHEI Pharmaceuticals, Inc. United States
Housey Pharmaceutical Research Laboratories LLC United States
Neos Therapeutics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cerimon Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.